GU-01: Glycyrrhizin in Prostate Cancer

This is a pilot, randomized, window-of-opportunity treatment trial in which participants with previously untreated prostate cancer (PCa) who are candidates for surgery (radical prostatectomy)

Trial Details

NCT ID
NCT06378346
Phase
PHASE2
Sponsor
University of Illinois Chicago
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • Observation
  • Glycyrrhizin - 75 mg
  • Glycyrrhizin - 150 mg
Locations (sample)
  • Chicago, Illinois, United States|41.85003,-87.65005

Key Eligibility Criteria

  • Age ≥ 18 years of age at time of consent
  • ECOG performance status of 0, 1, or 2
  • Histologic diagnosis of prostate cancer
  • Patient suitable for radical prostatectomy as determined by surgical team

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →